Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India.

Krishna Pandey, V N R Das, Dharmendra Singh, Sushmita Das, C S Lal, N Verma, S Bimal, R K Topno, N A Siddiqui, R B Verma, P K Sinha, Pradeep Das
Author Information
  1. Krishna Pandey: Rajendra Memorial Research Institute of Medical Sciences (Indian Council of Medical Research), Agamkuan, Patna, Bihar, India. drkrishnapandey@yahoo.com

Abstract

Post kala-azar dermal leishmaniasis (PKDL) is a skin manifestation that usually develops after treatment of visceral leishmaniasis (VL), a major public health problem in India. The diagnosis and management of PKDL is complex. This is the first case report from India in which PKDL occurred after paromomycin treatment for VL in an Indian patient.

References

  1. Trans R Soc Trop Med Hyg. 2001 Apr;95 Suppl 1:S59-76 [PMID: 11370251]
  2. J Clin Microbiol. 2001 Mar;39(3):849-54 [PMID: 11230394]
  3. Int J Dermatol. 1995 Sep;34(9):668-9 [PMID: 7591476]
  4. PLoS Negl Trop Dis. 2011 Feb 08;5(2):e960 [PMID: 21347452]
  5. Am J Trop Med Hyg. 2009 Mar;80(3):336-8 [PMID: 19270277]

MeSH Term

Adult
Antiprotozoal Agents
Female
Humans
Leishmania donovani
Leishmaniasis, Cutaneous
Leishmaniasis, Visceral
Paromomycin
Secondary Prevention

Chemicals

Antiprotozoal Agents
Paromomycin

Word Cloud

Created with Highcharts 10.0.0leishmaniasisPKDLIndiadermaltreatmentvisceralVLparomomycinpatientPostkala-azarskinmanifestationusuallydevelopsmajorpublichealthproblemdiagnosismanagementcomplexfirstcasereportoccurredIndianPost-kala-azartreatedinjectable

Similar Articles

Cited By